Aravax will present topline Phase 2 clinical trial results for [...]

AC Immune has received FDA Fast Track designation and IND [...]

BioVie has reported topline results from a Phase 2 trial [...]

ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]

Amorphical has completed patient enrolment in a Phase 2 trial [...]

Anixa Biosciences is advancing its breast cancer vaccine programme towards [...]

AmacaThera has been named Emerging Company of the Year by [...]

NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]

Cereno Scientific has broadened the clinical development focus of its [...]